Bio Plus (099430.KQ) Earnings Analysis
Bio Plus (099430.KQ) has no confirmed upcoming earnings date. Trailing P/E 15.89.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 099430.KQ next report earnings?
No confirmed upcoming earnings date is currently scheduled for 099430.KQ. This page updates as the calendar is published.
099430.KQ earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-14 | 109 KRW | n/a | n/a | n/a |
| 2026-02-13 | 31.21 KRW | n/a | n/a | n/a |
| 2025-11-14 | 53 KRW | n/a | n/a | n/a |
| 2024-12-31 | 53.96 KRW | n/a | n/a | n/a |
| 2024-09-30 | 58 KRW | n/a | n/a | n/a |
099430.KQ valuation and analyst view
| Trailing P/E | 15.89 |
|---|---|
| Trailing EPS | 228.09 KRW |
| Price / book | 1.27 |
| Dividend yield | 1.36% |
| Market cap | 216.01B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Bio Plus (099430.KQ)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for 099430.KQ. This page updates as the calendar is published.
Did 099430.KQ beat earnings last quarter?
Consensus estimate data was not available for 099430.KQ's 2026-05-14 report.
What is 099430.KQ's current P/E ratio and EPS?
099430.KQ trades at a trailing P/E of 15.89 on trailing EPS of 228.08754019785198 KRW.
What do analysts rate 099430.KQ?
099430.KQ has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.